Hyperfine

Hyperfine – My company/technology is advanced analytics software for personalized medicine – the goal for my company is to assist in the creation of cures. Hyperfine Team: Bridget Osetinksy, CEO…

Read More

Zakan Theraputics

Zakan Therapeutics — A biological therapeutic that can directly attack metastatic cancer cells by delivering a payload of anti-cancer compounds while bypassing healthy cells. Zakan Theraputics Team: Arthee Jahangir Benjamin…

Read More

Ichor Biologics

A validated platform for the isolation of human monoclonal antibodies (mAbs), which neutralize emerging and re-emerging infectious diseases. Ichor Biologics Team: Raymond Alvarez Justin Ring

Read More

Energizing Solutions

We will develop an evidence-based diet and physical activity assessment and intervention tool to facilitate compliance with prescribed regimens (i.e., diabetes, cardiovascular disease, weight loss). Energizing Solutions Team: Jeannette Beasley,…

Read More

Innovene, Inc.

Innovene has designed a new class of medications from safe plant-derived components; TriCurin will target the unmet medical need of treating patients with oncogenic human papillomavirus infections. Innovene Team: Mario…

Read More

Seeq

Seeq aims to advance precision medicine by creating a billion-person scale genomics dataset and making genome exploration approachable and inexpensive for consumers and researchers. Team: Kaja Wasik

Read More

Ardent

Ardent has developed technologies to transform “energy-storing” white adipose tissue (WAT) into “energy-burning” brown adipose tissue (BAT) for treatment of obesity, diabetes, and metabolic disease. Team: Luis Santos Brian Gillette

Read More

Veripad

Veripad has created the most affordable and accessible system for checking the quality of medicines by using a paper chemical test card and companion mobile app.   Team: Executive Leadership…

Read More

Chemitope Glycopeptide

Chemitope specializes in the chemical synthesis of complex glycopeptides for use in challenging vaccine applications, such as HIV. Team: Baptiste Aussedat, PhD William Walkowicz, PhD

Read More